Clinical trial
A Research Study for Patients With Overactive Bladder
NCT00168454 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00168454 |
|---|---|
| Title | A Research Study for Patients With Overactive Bladder |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Overactive Bladder, Urinary Incontinence |
| Intervention type | Biological, Drug |
| Interventions | botulinum toxin Type A, Placebo |
| Enrollment | 313 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 6, 2013 |
| Countries | Belgium, Canada, Germany, Poland, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: